CEACAM1 Is Associated With the Suppression of Natural Killer Cell Function in Patients With Chronic Hepatitis C

Natural killer cells (NK cells) play an essential role in the immunological mechanism underlying chronic hepatitis C (CHC). Impairment of NK cell function facilitates persistent infection with hepatitis C virus (HCV) and hepatocellular carcinogenesis. However, the mechanism by which NK cell activity is suppressed in CHC is not completely understood. In this study, we focused on carcinoembryonic antigen–related cell‐adhesion molecule 1 (CEACAM1). CEACAM1 is thought to suppress NK cell function. We examined the effect of CEACAM1 on NK cell function in CHC. We investigated the function of CEACAM1 in vitro using Huh7.5.1 cells and the HCV‐Japanese fulminant hepatitis (JFH)‐1 strain. We analyzed serum CEACAM1 level, NK cell function, and CEACAM1 messenger RNA (mRNA) level in human liver samples. Levels of CEACAM1 on the cell surface, CEACAM1 mRNA levels, and soluble CEACAM1 levels in supernatants were significantly higher in Huh7.5.1 cells infected with JFH‐1 (Huh7.5.1/JFH‐1 cells) than in Huh7.5.1 cells. Significantly higher NK cell cytotoxicity was observed toward K562 cells after coculture with CEACAM1 knockout Huh7.5.1/JFH‐1 cells than after coculture with Huh7.5.1/JFH‐1 cells. CEACAM1 expression was induced by the HCV E2 glycoprotein in HCV infection. Significantly higher serum CEACAM1 levels were detected in patients with CHC compared with healthy subjects and patients who achieved sustained virological responses. The expression of CD107a on NK cells from patients with CHC was negatively correlated with serum CEACAM1 levels. Significantly higher levels of CEACAM1 mRNA were detected in HCV‐infected livers compared with uninfected livers. Conclusion: CEACAM1 expression was induced in hepatocytes following HCV infection and decreased NK cell cytotoxicity. These results demonstrate a possible role for CEACAM1 in the pathogenesis of CHC and hepatocellular carcinoma progression.

[1]  Y. Matsuura,et al.  Host-derived apolipoproteins play comparable roles with viral secretory proteins Erns and NS1 in the infectious particle formation of Flaviviridae , 2017, PLoS pathogens.

[2]  西尾 啓 CD14⁺ Monocyte-Derived Galectin-9 Induces Natural Killer Cell Cytotoxicity in Chronic Hepatitis C , 2017 .

[3]  Y. Maehara,et al.  Quasispecies of Hepatitis C Virus Participate in Cell-Specific Infectivity , 2017, Scientific Reports.

[4]  N. Hiramatsu,et al.  CD14+ monocyte‐derived galectin‐9 induces natural killer cell cytotoxicity in chronic hepatitis C , 2017, Hepatology.

[5]  T. Tatsumi,et al.  Impact of natural killer cells on chronic hepatitis C and hepatocellular carcinoma , 2015, Hepatology research : the official journal of the Japan Society of Hepatology.

[6]  J. Murray,et al.  Direct‐acting antiviral drug approvals for treatment of chronic hepatitis C virus infection: Scientific and regulatory approaches to clinical trial designs , 2015, Hepatology.

[7]  B. Rehermann Natural Killer Cells in Viral Hepatitis , 2015, Cellular and molecular gastroenterology and hepatology.

[8]  L. Mishra,et al.  CEACAM1 Long Cytoplasmic Domain Isoform is Associated with Invasion and Recurrence of Hepatocellular Carcinoma , 2014, Annals of Surgical Oncology.

[9]  H. Dienemann,et al.  Carcinoembryonic antigen (CEA)-related cell adhesion molecules are co-expressed in the human lung and their expression can be modulated in bronchial epithelial cells by non-typable Haemophilus influenzae, Moraxella catarrhalis, TLR3, and type I and II interferons , 2013, Respiratory Research.

[10]  E. Wang,et al.  The paradox of NKp46+ natural killer cells: drivers of severe hepatitis C virus-induced pathology but in-vivo resistance to interferon α treatment , 2013, Gut.

[11]  J. Nattermann,et al.  Natural killer p46High expression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosis , 2012, Hepatology.

[12]  Y. Maehara,et al.  Expression of MicroRNA miR-122 Facilitates an Efficient Replication in Nonhepatic Cells upon Infection with Hepatitis C Virus , 2012, Journal of Virology.

[13]  Jeon‐Han Park,et al.  Cell-to-Cell Contact with Hepatitis C Virus-Infected Cells Reduces Functional Capacity of Natural Killer Cells , 2011, Journal of Virology.

[14]  M. Caligiuri,et al.  Innate or Adaptive Immunity? The Example of Natural Killer Cells , 2011, Science.

[15]  N. Kato,et al.  Elimination of Hepatitis C Virus from Hepatocytes by a Selective Activation of Therapeutic Molecules , 2011, PloS one.

[16]  Jessica A. Randall,et al.  Increased natural killer cell cytotoxicity and NKp30 expression protects against hepatitis C virus infection in high‐risk individuals and inhibits replication in vitro , 2010, Hepatology.

[17]  Céline Hernandez,et al.  Hepatitis C Virus (HCV) Evades NKG2D-Dependent NK Cell Responses through NS5A-Mediated Imbalance of Inflammatory Cytokines , 2010, PLoS pathogens.

[18]  A. Little,et al.  Association of NKG2A with treatment for chronic hepatitis C virus infection , 2010, Clinical and experimental immunology.

[19]  Barbara Rehermann,et al.  Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence. , 2009, The Journal of clinical investigation.

[20]  P. Tien,et al.  Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients. , 2008, Clinical immunology.

[21]  N. Greenberg,et al.  NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. , 2008, Immunity.

[22]  G. Feldmann,et al.  Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C , 2005, Gut.

[23]  S. Gray-Owen,et al.  CEACAM1: contact-dependent control of immunity , 2006, Nature Reviews Immunology.

[24]  N. Hayashi,et al.  Antiviral therapy for chronic hepatitis C: past, present, and future , 2005, Journal of Gastroenterology.

[25]  N. Hayashi,et al.  Negative Regulation of NK Cell Activities by Inhibitory Receptor CD94/NKG2A Leads to Altered NK Cell-Induced Modulation of Dendritic Cell Functions in Chronic Hepatitis C Virus Infection1 , 2004, The Journal of Immunology.

[26]  O. Mandelboim,et al.  CD66a Interactions Between Human Melanoma and NK Cells: A Novel Class I MHC-Independent Inhibitory Mechanism of Cytotoxicity1 , 2002, The Journal of Immunology.

[27]  S. Nuti,et al.  Inhibition of Natural Killer Cells through Engagement of CD81 by the Major Hepatitis C Virus Envelope Protein , 2002, The Journal of experimental medicine.

[28]  D. R. Taylor,et al.  Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. , 1999, Science.

[29]  J. Silver,et al.  Replication of Subgenomic Hepatitis C Virus Rnas in a Hepatoma Cell Line , 1999 .

[30]  R. Paxton,et al.  Differential Regulation of Carcinoembryonic Antigen and Biliary Glycoprotein by 7-Interferon 1 , 2006 .

[31]  R. Paxton,et al.  Differential regulation of carcinoembryonic antigen and biliary glycoprotein by gamma-interferon. , 1993, Cancer research.